JP3294415B2 - Method for producing fluorescent labeling reagent - Google Patents
Method for producing fluorescent labeling reagentInfo
- Publication number
- JP3294415B2 JP3294415B2 JP35085193A JP35085193A JP3294415B2 JP 3294415 B2 JP3294415 B2 JP 3294415B2 JP 35085193 A JP35085193 A JP 35085193A JP 35085193 A JP35085193 A JP 35085193A JP 3294415 B2 JP3294415 B2 JP 3294415B2
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- cyanine dye
- group
- amino group
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007850 fluorescent dye Substances 0.000 title claims description 21
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 13
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- 238000001215 fluorescent labelling Methods 0.000 title claims description 11
- 239000000975 dye Substances 0.000 claims description 36
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims description 30
- 125000003277 amino group Chemical group 0.000 claims description 23
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 20
- 125000001174 sulfone group Chemical group 0.000 claims description 17
- 229920001661 Chitosan Polymers 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 16
- 108090001008 Avidin Proteins 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- IRFSXVIRXMYULF-UHFFFAOYSA-N 1,2-dihydroquinoline Chemical compound C1=CC=C2C=CCNC2=C1 IRFSXVIRXMYULF-UHFFFAOYSA-N 0.000 claims 1
- 239000000243 solution Substances 0.000 description 23
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 17
- 239000013307 optical fiber Substances 0.000 description 17
- 239000000427 antigen Substances 0.000 description 16
- 102000036639 antigens Human genes 0.000 description 16
- 108091007433 antigens Proteins 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- GKQLYSROISKDLL-UHFFFAOYSA-N EEDQ Chemical compound C1=CC=C2N(C(=O)OCC)C(OCC)C=CC2=C1 GKQLYSROISKDLL-UHFFFAOYSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000004382 Amylase Substances 0.000 description 5
- 102000013142 Amylases Human genes 0.000 description 5
- 108010065511 Amylases Proteins 0.000 description 5
- 235000019418 amylase Nutrition 0.000 description 5
- 229960002685 biotin Drugs 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 238000003018 immunoassay Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- -1 rhodamine isothiocyanate Chemical class 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- FBPINGSGHKXIQA-UHFFFAOYSA-N 2-amino-3-(2-carboxyethylsulfanyl)propanoic acid Chemical compound OC(=O)C(N)CSCCC(O)=O FBPINGSGHKXIQA-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- HNRMBZVOHFQZRI-UHFFFAOYSA-N butyl 2-butoxy-2H-quinoline-1-carboxylate Chemical compound CCCCOC1C=CC2=CC=CC=C2N1C(=O)OCCCC HNRMBZVOHFQZRI-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- DUKQZMHSXLRNSN-UHFFFAOYSA-N ethanol;nickel Chemical compound [Ni].CCO DUKQZMHSXLRNSN-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- SMZOUNBHNKKAEI-UHFFFAOYSA-N methyl 2-propoxy-2H-quinoline-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)C(OCCC)C=CC2=C1 SMZOUNBHNKKAEI-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LGQLOGILCSXPEA-UHFFFAOYSA-L nickel sulfate Chemical compound [Ni+2].[O-]S([O-])(=O)=O LGQLOGILCSXPEA-UHFFFAOYSA-L 0.000 description 1
- 229910000363 nickel(II) sulfate Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Indole Compounds (AREA)
- Luminescent Compositions (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、蛍光免疫測定法に用い
る蛍光標識試薬の製造方法に関する。より詳しくは、ス
ルホン基とカルボキシル基とを併せ持つ水溶性シアニン
色素とアミノ基を有する高分子化合物とをカルボキシル
基を介してアミノ基と選択的に結合させることを特徴と
する蛍光標識試薬の製造方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing a fluorescent labeling reagent used in a fluorescent immunoassay. More specifically, a method for producing a fluorescent labeling reagent, wherein a water-soluble cyanine dye having both a sulfone group and a carboxyl group and a polymer compound having an amino group are selectively bonded to an amino group via a carboxyl group. About.
【0002】[0002]
【従来の技術・発明が解決しようとする課題】従来、抗
原、抗体の濃度の測定方法としてはラジオアイソトープ
や酵素で抗原や抗体を標識する方法が用いられてきた
が、これらの方法は感度、安全性などの面で問題があ
り、これらの方法に代わって蛍光色素で抗原や抗体を標
識し、これを用いて抗原や抗体の濃度を測定する方法が
種々研究されている。2. Description of the Related Art Conventionally, as a method of measuring the concentration of an antigen or an antibody, a method of labeling the antigen or the antibody with a radioisotope or an enzyme has been used. There are problems in terms of safety and the like, and instead of these methods, various methods for labeling an antigen or antibody with a fluorescent dye and measuring the concentration of the antigen or antibody using the label have been studied.
【0003】例えば、特開昭59−501873号(米
国特許番号第4852809号)などでは、光ファイバ
ーの側面に抗原、抗体を結合させ、蛍光色素で標識した
抗体、抗原をこの光ファイバー表面で免疫反応させると
ともに、この光ファイバーに励起光を導波することによ
り、光ファイバー上の蛍光色素を励起させ、生ずる蛍光
を光ファイバーの出射端面で反射させ、光ファイバーの
入射端面から蛍光と残余の励起光を取り出し、これをビ
ームスプリッターを経由することにより分光させ、蛍光
のみを測定する方法が記載されている。For example, in Japanese Patent Application Laid-Open No. 59-501873 (US Pat. No. 4,852,809), an antigen and an antibody are bound to the side of an optical fiber, and the antibody and the antigen labeled with a fluorescent dye are immunoreacted on the surface of the optical fiber. At the same time, the excitation light is guided to the optical fiber to excite the fluorescent dye on the optical fiber, the generated fluorescence is reflected at the emission end face of the optical fiber, and the fluorescence and the remaining excitation light are taken out from the incidence end face of the optical fiber. A method is described in which spectroscopy is performed by passing through a beam splitter, and only fluorescence is measured.
【0004】従来よりこのような蛍光免疫測定法におい
ては、標識物としてフルオレセインイソチオシアネー
ト、ローダミンイソチオシアネートなどの蛍光色素で修
飾された蛍光標識抗原や蛍光標識抗体が用いられてき
た。しかしながら、このような蛍光標識抗原や蛍光標識
抗体は、一つの抗原又は抗体に結合する蛍光色素の量が
一つであるため,感度の改善が困難であった。また、ロ
ーダミンやフルオレセイン等の蛍光色素は、励起波長が
400nm付近であるため、励起光源が大型で、高価で
あるという欠点を持っていた。そのため、これらの蛍光
色素に代えて、630nm帯で励起するシアニン色素で
修飾されたアビジンを用いてビオチン化抗原やビオチン
化抗体を標識することにより、He−Neレーザを光源
として使用可能な蛍光標識抗原や蛍光標識抗体が開発さ
れている(WO90/13029公報)。Conventionally, in such a fluorescent immunoassay, a fluorescently labeled antigen or a fluorescently labeled antibody modified with a fluorescent dye such as fluorescein isothiocyanate or rhodamine isothiocyanate has been used as a label. However, with such a fluorescently labeled antigen or fluorescently labeled antibody, it is difficult to improve the sensitivity because the amount of fluorescent dye that binds to one antigen or antibody is one. In addition, fluorescent dyes such as rhodamine and fluorescein have the disadvantage that the excitation light source is large and expensive because the excitation wavelength is around 400 nm. Therefore, instead of these fluorescent dyes, a biotinylated antigen or a biotinylated antibody is labeled with avidin modified with a cyanine dye excited in a 630 nm band, so that a fluorescent label that can use a He-Ne laser as a light source is used. Antigens and fluorescently labeled antibodies have been developed (WO90 / 13029).
【0005】しかし、従来の蛍光色素は、水溶媒系で溶
けにくく、また溶解しても加水分解を生じるなど大変不
安定であるため、反応試薬の作成が困難であった。そこ
で、この問題を解決するため、スルホン基とカルボキシ
ル基とを併せ持つ水溶性のシアニン色素が開発され、こ
れとアビジン等のアミノ基を持つ化合物との結合には、
カルボジイミド類が縮合剤として使用されてきた(J.
C.Seehan,G.P.Hess,J.Am.Ch
em.Soc.,77,1067(1955))。とこ
ろで、縮合剤としてカルボジイミド類を用いると、スル
ホン基とカルボキシル基とを併せ持つ水溶性のシアニン
色素の場合は、解離度の高いスルホン基の方がやや反応
選択性が高いため、スルホン基が選択的に活性化されて
アミノ基と結合し、その結果遊離のカルボキシル基を有
する水溶性の低い結合体が優先的に生じ、水溶性の高い
遊離のスルホン基を有する結合体の収率が低下するとい
う問題がある。However, conventional fluorescent dyes are hardly soluble in an aqueous solvent system, and are very unstable, such as being hydrolyzed when dissolved, so that it has been difficult to prepare a reaction reagent. In order to solve this problem, a water-soluble cyanine dye having both a sulfone group and a carboxyl group has been developed.
Carbodiimides have been used as condensing agents (J.
C. Seehan, G .; P. Hess, J.M. Am. Ch
em. Soc. , 77 , 1067 (1955)). By the way, when carbodiimides are used as a condensing agent, in the case of a water-soluble cyanine dye having both a sulfone group and a carboxyl group, a sulfone group having a high degree of dissociation has a slightly higher reaction selectivity, so that a sulfone group is selectively used. Is activated to bind to an amino group, and as a result, a low water-soluble conjugate having a free carboxyl group is preferentially generated, and the yield of a conjugate having a high water-soluble free sulfone group is reduced. There's a problem.
【0006】[0006]
【課題を解決するための手段】そこで本発明者らは、前
記の課題を解決するために鋭意検討した。その結果、縮
合剤として、ペプチド合成の分野でカップリング試薬と
して知られているN−エトキシカルボニル−2−エトキ
シ−1,2−ジヒドロキノリン(EEDQ)(D.Be
lleau,G.Malek,J.Am.Chem.S
oc.,90,1651(1968))を用いた場合、
スルホン基とカルボキシル基とを併せ持つ水溶性のシア
ニン色素であっても、カルボキシル基とアミノ基が結合
した水溶性の高い結合体が高収率で得られることを見い
出し、さらに研究を進めて本発明を完成するに至った。The present inventors have made intensive studies to solve the above-mentioned problems. As a result, as a condensing agent, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (D.Be), which is known as a coupling reagent in the field of peptide synthesis.
lleau, G .; See Malek, J.M. Am. Chem. S
oc. , 90 , 1651 (1968)),
Even with a water-soluble cyanine dye having both a sulfone group and a carboxyl group, it has been found that a highly water-soluble conjugate in which a carboxyl group and an amino group are bonded can be obtained in a high yield, and further research has been carried out. Was completed.
【0007】即ち、本発明の要旨は、(1)スルホン基
とカルボキシル基を併せ持つ水溶性シアニン色素と、ア
ミノ基を有する高分子化合物とを結合させて蛍光標識試
薬を製造する方法において、N−アルコキシカルボニル
−2−アルコキシ−1,2−ジヒドロキノリンを作用さ
せ、カルボキシル基とアミノ基を選択的に結合させるこ
とを特徴とする蛍光標識試薬の製造方法、(2)スルホ
ン基とカルボキシル基を併せ持つ水溶性シアニン色素が
一般式(I)、(II)又は(III)により表されるシアニ
ン色素であることを特徴とする上記(1)記載の製造方
法、並びにThat is, the gist of the present invention is to provide (1) a method for producing a fluorescent labeling reagent by combining a water-soluble cyanine dye having both a sulfone group and a carboxyl group with a polymer compound having an amino group. A method for producing a fluorescent labeling reagent, wherein an alkoxycarbonyl-2-alkoxy-1,2-dihydroquinoline is allowed to act to selectively bind a carboxyl group and an amino group, and (2) a method having both a sulfone group and a carboxyl group. The method according to the above (1), wherein the water-soluble cyanine dye is a cyanine dye represented by the general formula (I), (II) or (III), and
【0008】[0008]
【化4】 Embedded image
【0009】(式中、RはH+ 、Na+ 、K+ 、L
i+ 、N+ H(C2 H5 )3 、NH4 + 、またはピリジ
ニウムイオンを表す。)(Wherein R is H + , Na + , K + , L
i + , N + H (C 2 H 5 ) 3 , NH 4 + , or pyridinium ion. )
【0010】[0010]
【化5】 Embedded image
【0011】(式中、RはH+ 、Na+ 、K+ 、L
i+ 、N+ H(C2 H5 )3 、NH4 + 、またはピリジ
ニウムイオンを表す。)(Where R is H + , Na + , K + , L
i + , N + H (C 2 H 5 ) 3 , NH 4 + , or pyridinium ion. )
【0012】[0012]
【化6】 Embedded image
【0013】(式中、RはH+ 、Na+ 、K+ 、L
i+ 、N+ H(C2 H5 )3 、NH4 + 、またはピリジ
ニウムイオンを表す。) (3)アミノ基を有する高分子化合物がキトサン、スル
ホン化キトサン、ポリガラクトサミン、ポリノイラミン
酸、抗体、アビジン、およびプロテインAからなる群よ
り選ばれるものである上記(1)または(2)記載の製
造方法に関する。(Wherein R is H + , Na + , K + , L
i + , N + H (C 2 H 5 ) 3 , NH 4 + , or pyridinium ion. (3) The above (1) or (2), wherein the high molecular compound having an amino group is selected from the group consisting of chitosan, sulfonated chitosan, polygalactosamine, polyneuraminic acid, antibody, avidin, and protein A. It relates to a manufacturing method.
【0014】本発明の方法に用いられる蛍光標識試薬
は、分子中にカルボキシル基とスルホン基とを併せ持つ
シアニン色素であれば特に制限されるものではなく、具
体的には、一般式(I)に示される構造式を有する色素
NK3682(日本感光色素研究所製)およびその塩、
一般式(II)に示される構造式を有する色素NK375
9(日本感光色素研究所製)およびその塩、一般式(II
I)に示される構造式を有する色素NK3942(日本感
光色素研究所製)およびその塩等が挙げられる。本発明
で用いるこれらのシアニン色素は、赤外域を吸収する蛍
光色素であるため、小型で高出力かつ低価格な半導体レ
ーザを光源として使用することができる。従って、優れ
た蛍光免疫測定法の実現を可能とする。The fluorescent labeling reagent used in the method of the present invention is not particularly limited as long as it is a cyanine dye having both a carboxyl group and a sulfone group in the molecule. A dye NK3682 (manufactured by Nippon Kogaku Dye Laboratories) having the structural formula shown below and a salt thereof
Dye NK375 having a structural formula represented by the general formula (II)
9 (manufactured by Japan Photographic Dye Laboratories), its salt, and the general formula (II
Dye NK3942 (manufactured by Japan Photographic Dye Laboratories) having the structural formula shown in I) and salts thereof and the like. Since these cyanine dyes used in the present invention are fluorescent dyes that absorb the infrared region, a small, high-output, and low-cost semiconductor laser can be used as a light source. Therefore, an excellent fluorescent immunoassay can be realized.
【0015】本発明の方法におけるシアニン色素とアミ
ノ基を有する高分子化合物との反応は、N−アルコキシ
カルボニル−2−アルコキシ−1,2−ジヒドロキノリ
ン(AADQ)により、シアニン色素中のスルホン基と
カルボキシル基のうち、非プロトン性溶媒中でカルボキ
シル基のみを活性化し、アミノ基と反応させることによ
り行われる。AADQ(IV) は、下記反応式に示すよう
に、一般に酸成分であるRCOOHと反応して中間体
(V)を生じ、この中間体は、徐徐に混合酸無水物(V
I)とキノリン(VII)とに分解する。この混合酸無水物
は、アミノ基を有する高分子化合物との反応で直ちにア
ミノ基と反応して酸アミド結合を形成する。従って、酸
成分として前記のようなカルボキシル基とスルホン基と
を併せもつシアニン色素を用いた場合、シアニン色素中
のカルボキシル基が反応し解離しているスルホン基は反
応に関与しないため、高い収率でカルボキシル基とアミ
ノ基との反応結合物を得ることが可能となる。AADQ
としては、前記のEEDQの他に、一般式(IV) におけ
るR’,R”を種々組合せたものが挙げられる。In the method of the present invention, the reaction between the cyanine dye and the polymer having an amino group is carried out by reacting the sulfone group in the cyanine dye with N-alkoxycarbonyl-2-alkoxy-1,2-dihydroquinoline (AADQ). Of the carboxyl groups, the reaction is performed by activating only the carboxyl group in an aprotic solvent and reacting with the amino group. AADQ (IV) generally reacts with RCOOH, which is an acid component, to produce an intermediate (V) as shown in the following reaction formula, and this intermediate is gradually mixed with an acid anhydride (V).
Decomposes into I) and quinoline (VII). This mixed acid anhydride reacts immediately with the amino group in the reaction with the polymer compound having an amino group to form an acid amide bond. Therefore, when a cyanine dye having both a carboxyl group and a sulfone group as described above is used as the acid component, the sulfone group in which the carboxyl group in the cyanine dye has reacted and dissociated does not participate in the reaction, so that a high yield is obtained. Thus, a reaction bond between a carboxyl group and an amino group can be obtained. AADQ
Examples thereof include various combinations of R ′ and R ″ in the general formula (IV) in addition to the EEDQ described above.
【0016】[0016]
【化7】 Embedded image
【0017】(式中、R’、R''はメチル、エチル、プ
ロピル、ブチル、イソブチルおよびペンチルの中から選
ばれるものである。) こうして得られるシアニン色素とアミノ基を有する高分
子化合物との結合物、すなわちシアニン色素標識高分子
化合物は、遊離のスルホン基を有するため水溶性に優れ
ている。(Wherein R ′ and R ″ are selected from methyl, ethyl, propyl, butyl, isobutyl and pentyl.) The cyanine dye thus obtained is combined with a polymer compound having an amino group. The conjugate, that is, the cyanine dye-labeled polymer compound has a free sulfone group and thus has excellent water solubility.
【0018】AADQによるシアニン色素とアミノ基を
有する高分子化合物との反応は、公知の方法によって行
うことができる。例えば、まず、シアニン色素をジメチ
ルホルムアミド、ジメチルアセトアミド等の有機溶媒に
溶解して氷冷した後、1〜2倍等量のAADQを添加
し、0〜4℃に0.5〜4時間静置する。この間に混合
酸無水物が形成される。一方、アミノ基を有する高分子
化合物を水に溶解して、氷冷する。これにシアニン色素
を含むジメチルホルムアミド等の溶液を添加し、0〜4
℃にて2〜18時間静置して反応させる。反応終了後、
未反応のシアニン色素およびAADQ等は除去すること
が好ましく、例えば透析法、遠心分離法、ゲル濾過法又
は限外濾過法などとアルコール、水等による洗浄との併
用によって除くことができる。The reaction between a cyanine dye and a polymer having an amino group by AADQ can be carried out by a known method. For example, first, after dissolving a cyanine dye in an organic solvent such as dimethylformamide or dimethylacetamide, and ice-cooling, add 1 to 2 equivalents of AADQ and leave at 0 to 4 ° C. for 0.5 to 4 hours. I do. During this time a mixed anhydride is formed. On the other hand, a polymer compound having an amino group is dissolved in water and cooled with ice. A solution such as dimethylformamide containing a cyanine dye is added to this,
The reaction is allowed to stand at 2 ° C. for 2 to 18 hours. After the reaction,
Unreacted cyanine dye, AADQ and the like are preferably removed, and can be removed by, for example, a combination of dialysis, centrifugation, gel filtration, ultrafiltration, etc., and washing with alcohol, water, or the like.
【0019】本発明に用いられるアミノ基を有する高分
子化合物としては、まず、キトサン、スルホン化キトサ
ン、ポリガラクトサミン、ポリノイラミン酸等のアミノ
グリカンおよびそれらの誘導体が挙げられる。これらの
アミノグリカン例えばキトサンの分子量は、通常104
〜105 程度であるが、反応活性基の数を増加させるた
め105 〜106 程度のものを使用するのが好ましい。
また、キトサンの水溶性を高めるため、スルホン化キト
サンを有利に用いることができる。また、アミノグリカ
ンの他に抗体、アビジン、プロテインA、ポリリジン等
のポリペプチド類も本発明に用いられるアミノ基を有す
る高分子化合物として有利に用いることができる。Examples of the high molecular compound having an amino group used in the present invention include aminoglycans such as chitosan, sulfonated chitosan, polygalactosamine and polyneuraminic acid, and derivatives thereof. The molecular weight of these aminoglycans such as chitosan is usually 10 4
Although it is about 10 5, it is preferable to use about 10 5 to 10 6 in order to increase the number of reactive groups.
In order to increase the water solubility of chitosan, sulfonated chitosan can be advantageously used. In addition to aminoglycans, polypeptides such as antibodies, avidin, protein A, and polylysine can also be advantageously used as the high molecular compound having an amino group used in the present invention.
【0020】なお、本発明の方法により製造される蛍光
標識試薬は、以下に記載される工程により、蛍光免疫測
定に使用される。説明の便宜上、本発明の方法により製
造されるシアニン色素修飾アビジンを使用する場合を例
にとる。[0020] The fluorescent labeling reagent produced by the method of the present invention is used in a fluorescent immunoassay by the following steps. For convenience of explanation, a case where a cyanine dye-modified avidin produced by the method of the present invention is used will be described as an example.
【0021】工程A:まず、測定対象物質(例えば、抗
原)に対する抗体を光ファイバーのコア表面に固定す
る。次いで、該抗体の結合した光ファイバーと測定対象
物質(抗原)を特異的に反応させて、光ファイバーのコ
ア表面上に抗体と測定対象物質(抗原)の結合した免疫
複合体(光ファイバーのコア表面−抗体−測定対象物
質)を形成する。Step A: First, an antibody against a substance to be measured (eg, an antigen) is immobilized on the core surface of an optical fiber. Next, the optical fiber to which the antibody is bound and the substance to be measured (antigen) are allowed to react specifically with each other, and an immune complex (the core surface of the optical fiber-antibody) in which the antibody and the substance to be measured (antigen) are bound on the core surface of the optical fiber. -Substance to be measured).
【0022】工程B:前記の測定対象物質(抗原)に対
して特異的な結合能を有する抗体の結合したビオチン化
アミノグリカン(抗体−アミノグリカン−ビオチン)と
本発明のシアニン色素修飾アビジン(アビジン−シアニ
ン色素)を反応させて、ビオチン−アビジンの結合を介
したシアニン色素標識抗体を調製する(抗体−アミノグ
リカン−ビオチン−アビジン−シアニン色素)。Step B: Biotinylated aminoglycan (antibody-aminoglycan-biotin) to which an antibody having specific binding ability to the above-mentioned substance to be measured (antigen) is bound, and the cyanine dye-modified avidin of the present invention (avidin) -Cyanine dye) to prepare a cyanine dye-labeled antibody via biotin-avidin bond (antibody-aminoglycan-biotin-avidin-cyanine dye).
【0023】工程C:工程Aで調製した免疫複合体の末
端抗原と工程Bで調製したシアニン色素標識抗体を反応
させて、光ファイバーのコア表面−抗体−測定対象物質
−抗体−アミノグリカン−ビオチン−アビジン−シアニ
ン色素の複合体を形成させ、750〜850nmの半導
体レーザを励起光源とする蛍光測定装置を用いて光ファ
イバーのコア表面に固定されたシアニン色素の蛍光を測
定する。Step C: The terminal antigen of the immune complex prepared in Step A is reacted with the cyanine dye-labeled antibody prepared in Step B, and the optical fiber core surface-antibody-substance to be measured-antibody-aminoglycan-biotin- An avidin-cyanine dye complex is formed, and the fluorescence of the cyanine dye fixed on the core surface of the optical fiber is measured using a fluorescence measurement device using a semiconductor laser of 750 to 850 nm as an excitation light source.
【0024】前記の説明においては、アミノ基を有する
高分子化合物としてアビジンを例にしたが、本発明の方
法に用いられるアミノ基を有する高分子化合物として
は、前記のようにアビジン以外にも抗体、プロテイン
A、キトサン、スルホン化キトサン、ポリガラクトサミ
ン、ポリノイラミン酸等のアミノグリカンが用いられ
る。光ファイバーのコア表面にシアニン色素を固定する
ために介在する化合物として、アビジンの場合にはビオ
チンが使用されるように、使用するアミノ基を有する高
分子化合物と特異的に結合する化合物が選択される。具
体的には、アビジンとビオチン、プロテインAと抗体な
どが好ましく、特にアビジンとビオチンの組み合わせが
最適である。キトサン、ポリガラクトサミン、ポリノイ
ラミン酸等のアミノグリカンの場合は、これらの抗体を
用いることができるが、キトサン等にビオチンを結合さ
せて、ビオチン化キトサン等とアビジンとを組み合わせ
て用いるのが便利である。In the above description, avidin is taken as an example of a polymer compound having an amino group. However, the polymer compound having an amino group used in the method of the present invention may be an antibody other than avidin as described above. And aminoglycans such as protein A, chitosan, sulfonated chitosan, polygalactosamine and polyneuraminic acid. As the intervening compound for fixing the cyanine dye on the core surface of the optical fiber, a compound that specifically binds to a polymer compound having an amino group to be used is selected, such as biotin in the case of avidin. . Specifically, avidin and biotin, protein A and an antibody are preferred, and a combination of avidin and biotin is particularly optimal. In the case of aminoglycans such as chitosan, polygalactosamine and polyneuraminic acid, these antibodies can be used.However, it is convenient to combine biotin with chitosan or the like and use biotinylated chitosan or the like with avidin. .
【0025】[0025]
【実施例】以下、実施例および比較例により本発明をさ
らに詳しく説明するが、本発明はこれらの実施例等によ
りなんら限定されるものではない。 実施例1 (1)キトサン2.5gを5%LiCl含有ジメチルア
セトアミド(DMA)500mlに懸濁し、ここへピリ
ジン−三酸化硫黄錯体18gを溶解し、60℃で24時
間反応させた。 (2)反応後、冷却しながら氷水を加え、さらにpH1
0に調整しながら最終的に約1リットルとした。 (3)遠心分離により沈澱を除去した後、上清をエバポ
レーションによって約500mlに濃縮し、さらにこれ
を蒸留水に対して透析し、DMA、ピリジンおよび生成
したNa2 SO4 を除去した。 (4)前記(3)の溶液に濃HClを加え、溶液の最終
濃度が0.08Nとなるように調製した。この溶液を1
00℃で2.5時間、加熱処理した。 (5)加熱後、氷浴中で冷却し、さらに6%NaOH水
溶液でpH10に調整し、生じた沈澱を遠心分離により
除去し、上清を得た。 (6)前記(5)の上清を蒸留水に対して一晩透析した
のち、これをエバポレーターにて濃縮乾固し、スルホン
化キトサン(S−C)標品を得た。EXAMPLES Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited to these Examples and the like. Example 1 (1) 2.5 g of chitosan was suspended in 500 ml of dimethylacetamide (DMA) containing 5% LiCl, and 18 g of a pyridine-sulfur trioxide complex was dissolved therein and reacted at 60 ° C. for 24 hours. (2) After the reaction, ice water was added while cooling, and pH
The final volume was adjusted to about 1 liter while adjusting to zero. (3) After removing the precipitate by centrifugation, the supernatant was concentrated to about 500 ml by evaporation, and this was dialyzed against distilled water to remove DMA, pyridine and generated Na 2 SO 4 . (4) Concentrated HCl was added to the solution of (3) to adjust the final concentration of the solution to 0.08N. This solution is
Heat treatment was performed at 00 ° C. for 2.5 hours. (5) After heating, the mixture was cooled in an ice bath, adjusted to pH 10 with a 6% aqueous NaOH solution, and the resulting precipitate was removed by centrifugation to obtain a supernatant. (6) The supernatant of the above (5) was dialyzed against distilled water overnight, and then concentrated and dried by an evaporator to obtain a sulfonated chitosan (SC) standard.
【0026】(7)NK3682の27.6mgを0.
5mlのジメチルホルムアミド(DMF)に溶解し、N
K3682が溶解した後、この液を氷浴中で冷却した。 (8)前記(7)の氷冷したNK3682溶液にEED
Q(和光純薬工業社製)10.4mgを加え、溶解した
後、4℃に2時間静置した。 (9)前記(6)で得られたS−C2mgを0.5ml
の水に溶解し、氷冷した後、前記(8)のEEDQによ
り活性化したNK3682の溶液0.5mlを加え、4
℃にて12時間反応させた。 (10)前記(9)の反応液にメタノールを約9ml加
え、限外濾過にて未反応のNK3682およびEEDQ
等を除去した。 (11)さらに2〜3回メタノールで洗浄したのち、メ
タノールを除去し、ここへ水3mlを加えて、NK36
82の結合したS−C(F−S−C)の水溶液を得た。(7) 27.6 mg of NK3682 was added in 0.1 part.
Dissolve in 5 ml of dimethylformamide (DMF) and add N
After K3682 was dissolved, the solution was cooled in an ice bath. (8) EED was added to the ice-cooled NK3682 solution of (7).
After adding and dissolving 10.4 mg of Q (manufactured by Wako Pure Chemical Industries, Ltd.), the mixture was allowed to stand at 4 ° C. for 2 hours. (9) 0.5 ml of 2 mg of the SC obtained in the above (6)
Was dissolved in water and cooled with ice, and 0.5 ml of the solution of NK3682 activated by EEDQ of (8) was added.
Reaction was performed at 12 ° C. for 12 hours. (10) About 9 ml of methanol was added to the reaction solution of the above (9), and unreacted NK3682 and EEDQ were added by ultrafiltration.
Etc. were removed. (11) After further washing with methanol for 2 to 3 times, the methanol was removed, and 3 ml of water was added thereto.
Thus, an aqueous solution of 82 bonded SC (FSC) was obtained.
【0027】(12)前記(11)で得られたF−S−
C水溶液に3mgのヤギ由来抗ヒトIg抗体を溶解し、
さらにここへ5mgの1−エチル−3−(3−ジメチル
アミノプロピル)カルボジイミド塩酸塩(WSC)を加
え、4℃で一晩反応させた。 (13)ゲル濾過によって、未反応の抗体、F−S−
C、およびWSC等を除去し、ヤギ由来抗ヒトIg抗体
の結合したF−S−C(F−S−C−Ab)を得た。F
−S−C−Abとして回収できた抗体量は2.8mg
(93.3%)であった。(12) The F-S- obtained in the above (11)
Dissolve 3 mg of goat-derived anti-human Ig antibody in C aqueous solution,
Further, 5 mg of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (WSC) was added thereto and reacted at 4 ° C. overnight. (13) Unreacted antibody, FS-
C, WSC and the like were removed to obtain FSC (FSC-Ab) to which a goat-derived anti-human Ig antibody was bound. F
The amount of the antibody recovered as -SC-Ab was 2.8 mg.
(93.3%).
【0028】(14)ポリメタクリル酸メチルからなる
樹脂製光ファイバー(三菱レイヨン(株)製)を3cm
に切り、両端面をエタノールを潤滑剤としてポリシング
フィルムで研磨した。 (15)0.5mlの水に10mgの硫酸ニッケルを溶
かし、次いで2.5mlのエタノールを加えた。この際
に生じる沈澱を遠心分離にて除去し、採取した上澄みを
ニッケル−エタノール溶液とした。次にエタノール溶媒
の20mM水酸化カリウム溶液0.4mlにニッケル−
エタノール溶液0.1mlと50%グルタルアルデヒド
50μlを添加し混合して、処理溶液とした。 (16)前記(14)の光ファイバーの片面を前記(1
5)の処理溶液中に、50℃で10分間浸漬した後、2
0mM塩酸、次にPBSで洗浄した。次にこの光ファイ
バーを2mg/mlのヒト膵アミラーゼ溶液に浸漬し、
4℃に一晩静置した。 (17)光ファイバーを溶液から取り出し、1%水素化
ホウ素ナトリウム水溶液に15分間浸漬した後、PBS
で洗浄して、ヒト膵アミラーゼ固定化センサーとし、こ
れを検出部とした。(14) A resin optical fiber made of polymethyl methacrylate (manufactured by Mitsubishi Rayon Co., Ltd.) of 3 cm
And both ends were polished with a polishing film using ethanol as a lubricant. (15) 10 mg of nickel sulfate was dissolved in 0.5 ml of water, and then 2.5 ml of ethanol was added. The precipitate formed at this time was removed by centrifugation, and the collected supernatant was used as a nickel-ethanol solution. Next, nickel-0.4 ml of 20 mM potassium hydroxide solution of ethanol solvent was added.
0.1 ml of an ethanol solution and 50 μl of 50% glutaraldehyde were added and mixed to obtain a treatment solution. (16) One side of the optical fiber of (14) is
After immersion in the treatment solution of 5) at 50 ° C. for 10 minutes,
Washed with 0 mM hydrochloric acid, then with PBS. Next, this optical fiber is immersed in a 2 mg / ml human pancreatic amylase solution,
Leave at 4 ° C. overnight. (17) The optical fiber is taken out of the solution, immersed in a 1% sodium borohydride aqueous solution for 15 minutes, and then PBS
After washing, a sensor for immobilizing human pancreatic amylase was used as a detection unit.
【0029】(18)濃度既知のヒト膵アミラーゼ抗体
溶液の中に、前記(17)の検出部を20分間浸漬し、
前記(13)で調製したF−S−C−Abの溶液中に2
0分間浸漬した。次いで、0.05%トゥイーン20含
有PBS(Tween PBS)で洗浄後、1個のレー
ザを使用する蛍光測定系である図1に示す装置を用い
て、780nm半導体レーザ系で測定したところ、0.
3ng/mlまで測定できた。(18) The detection unit of (17) is immersed in a human pancreatic amylase antibody solution having a known concentration for 20 minutes.
In the solution of FSC-Ab prepared in the above (13), 2
Dipped for 0 minutes. Next, after washing with PBS containing 0.05% Tween 20 (Tween PBS), measurement was performed with a 780 nm semiconductor laser system using the apparatus shown in FIG. 1 which is a fluorescence measurement system using one laser.
It was able to measure up to 3 ng / ml.
【0030】比較例1 (1)実施例1の(1)〜(6)と同様の方法でS−C
標品を得た。 (2)前記(1)のS−C2mgを0.5mlの水に溶
解し、27.6mgのNK3682をDMFに溶解し
て、両液を混合し、ここへ水溶性カルボジイミド(WS
C)を10mg加え、4℃にて12時間反応させた。 (3)実施例1の(10)〜(13)と同様の方法でF
−S−C−Abを得た。このとき、F−S−C−Abと
して回収できた抗体量は約0.4mgで、用いた抗体の
13.3%に過ぎなかったのに対し、実施例1で回収で
きた抗体量は前記のように90%以上の回収率であっ
た。この相違は、EEDQにより活性化されたNK36
82を用いた場合とWSCにより活性化されたNK36
82を用いた場合におけるF−S−Cの収率の相違およ
び得られたF−S−Cの水溶性の相違によるものと考え
られる。Comparative Example 1 (1) S-C by a method similar to (1) to (6) of Example 1
A sample was obtained. (2) 2 mg of the SC of the above (1) was dissolved in 0.5 ml of water, 27.6 mg of NK3682 was dissolved in DMF, and the two solutions were mixed, and water-soluble carbodiimide (WS
10 mg of C) was added and reacted at 4 ° C. for 12 hours. (3) F is obtained in the same manner as in (10) to (13) of the first embodiment.
-SC-Ab was obtained. At this time, the amount of the antibody recovered as FSC-Ab was about 0.4 mg, which was only 13.3% of the antibody used, whereas the amount of the antibody recovered in Example 1 was as described above. And the recovery rate was 90% or more. This difference is due to NK36 activated by EEDQ.
82 and NK36 activated by WSC
This is probably due to the difference in the yield of FSC when 82 was used and the difference in the water solubility of the obtained FSC.
【0031】実施例2 (1)5mgのNK3942を100μlのDMFに冷
却しながら溶解し、ここへ4mgのEEDQを加えて溶
解し、4℃にて2時間静置した。 (2)(株)日本バイオテスト研究所製のヤギ由来抗ヒ
トCRP抗体溶液1ml(13mg/ml)を5mMリ
ン酸緩衝液(pH7)にて4℃で4時間透析し、透析後
に前記(1)のNK3942溶液と混合し、4℃に16
時間静置した。 (3)5mMリン酸緩衝液(pH7)で平衡化したセフ
ァデックスG50カラムにてゲル濾過を行い、NK39
42の結合した抗ヒトCRP抗体(F−Ab)を得た。
このときF−Abとして回収できた抗体量は12.3m
g(94.6%)であった。 (4)ヒト膵アミラーゼの代わりに、抗ヒトCRP抗体
を用いた以外は実施例1の(14)〜(17)と同様の
方法で抗ヒトCRP抗体固定化センサーを作成し、これ
を検出部とした。 (5)濃度既知のCRP溶液中に前記(4)の検出部を
20分間浸漬し、次に、前記(3)で調製したF−Ab
溶液に20分間浸漬した。0.01%トゥイーン20含
有5mMリン酸緩衝液(pH7)で洗浄した後、図1に
示す装置を用いて780nm半導体レーザ系で測定した
ところ、2ng/mlまで測定できた。Example 2 (1) 5 mg of NK3942 was dissolved in 100 μl of DMF while cooling, 4 mg of EEDQ was added and dissolved, and the mixture was allowed to stand at 4 ° C. for 2 hours. (2) 1 ml (13 mg / ml) of a goat-derived anti-human CRP antibody solution manufactured by Nippon Biotest Laboratory Co., Ltd. was dialyzed against 5 mM phosphate buffer (pH 7) at 4 ° C. for 4 hours. ) With NK3942 solution and 4 ° C to 16 ° C.
Let stand for hours. (3) Gel filtration was performed using a Sephadex G50 column equilibrated with 5 mM phosphate buffer (pH 7), and NK39 was used.
Forty-two bound anti-human CRP antibodies (F-Abs) were obtained.
At this time, the amount of the antibody recovered as F-Ab was 12.3 m.
g (94.6%). (4) An anti-human CRP antibody-immobilized sensor was prepared in the same manner as in (14) to (17) of Example 1 except that an anti-human CRP antibody was used instead of human pancreatic amylase, and this was used as a detection unit. And (5) The detection unit of (4) is immersed in a CRP solution of known concentration for 20 minutes, and then the F-Ab prepared in (3) above
Immersion in the solution for 20 minutes. After washing with a 5 mM phosphate buffer (pH 7) containing 0.01% Tween 20, measurement was performed with a semiconductor laser system at 780 nm using the apparatus shown in FIG. 1, and it was possible to measure up to 2 ng / ml.
【0032】比較例2 (1)実施例2の(1)および(2)において、EED
Qによって活性化されたNK3942の代わりに、5m
gのNK3942をそのまま透析後の抗体溶液に溶か
し、さらに4mgのWSCを加えた以外は実施例2の
(2)および(3)と同様の方法でF−Abを得た。こ
のとき、F−Abとして回収できた抗体量は0.11m
g(回収率8.5%)であった。 (2)実施例2の(4)および(5)と同様の方法で測
定したところ、得られたF−Abが少なすぎたため、6
00ng/mlまでしか検出できなかった。実施例2と
比較例2とを比べると、NK3942と抗ヒトCRP抗
体との結合には、WSCよりもEEDQが遙かに優れて
いることが明らかであり、本発明の蛍光標識試薬の製造
方法においては、EEDQが極めて適しているといえ
る。Comparative Example 2 (1) In Example 2 (1) and (2), the EED
5m instead of NK3942 activated by Q
g-NK3942 was directly dissolved in the dialyzed antibody solution, and F-Ab was obtained in the same manner as in (2) and (3) of Example 2 except that 4 mg of WSC was added. At this time, the amount of antibody recovered as F-Ab was 0.11 m
g (recovery rate 8.5%). (2) When measured by the same method as in (4) and (5) of Example 2, the amount of F-Ab obtained was too small.
Only up to 00 ng / ml could be detected. Comparing Example 2 with Comparative Example 2, it is clear that EEDQ is much superior to WSC in binding NK3942 to an anti-human CRP antibody, and the method for producing a fluorescent labeling reagent of the present invention. , EEDQ is extremely suitable.
【0033】実施例3 実施例2において、NK3942の代わりにNK375
9を用いた以外は全く同様の方法で抗ヒトCRP抗体固
定化センサーを作成し、濃度既知のCRP溶液中のCR
Pを測定したところ、2ng/mlまで検出することが
できた。Example 3 In Example 2, NK375 was used instead of NK3942.
Example 9 An anti-human CRP antibody-immobilized sensor was prepared in exactly the same manner except that CR9 was used.
When P was measured, detection was possible up to 2 ng / ml.
【0034】実施例4 実施例1において、EEDQの代わりにN−メトキシカ
ルボニル−2−プロポキシ−1,2−ジヒドロキノリン
(MPDQ)を用いた以外は全く同様の方法で実施した
ところ、抗体は90%以上回収でき、かつ、ヒト膵臓ア
ミラーゼを0.3ng/mlまで測定することができ
た。Example 4 The procedure of Example 1 was repeated, except that N-methoxycarbonyl-2-propoxy-1,2-dihydroquinoline (MPDQ) was used instead of EEDQ. % Or more and human pancreatic amylase could be measured up to 0.3 ng / ml.
【0035】実施例5 実施例2において、EEDQの代わりにN−ブトキシカ
ルボニル−2−ブトキシ−1,2−ジヒドロキノリン
(BBDQ)を用いた以外は全く同様の方法で実施した
ところ、抗体は92%以上回収でき、かつ、CRPを2
ng/mlまで測定することができた。Example 5 The same procedure as in Example 2 was repeated except that N-butoxycarbonyl-2-butoxy-1,2-dihydroquinoline (BBDQ) was used instead of EEDQ. % Or more and 2 CRP
It was possible to measure up to ng / ml.
【0036】[0036]
【発明の効果】本発明の製造方法によれば、スルホン基
とカルボキシル基とを併せ持つシアニン色素を用いて水
溶性の高い蛍光標識試薬を高収率で製造することが可能
となり、高感度で低価格の免疫測定を容易にすることが
できる。According to the production method of the present invention, it is possible to produce a highly water-soluble fluorescent labeling reagent in a high yield using a cyanine dye having both a sulfone group and a carboxyl group. Price immunoassays can be facilitated.
【図1】図1は1個のレーザを使用する蛍光測定系の概
略図である。FIG. 1 is a schematic diagram of a fluorescence measurement system using one laser.
1 光ファイバー 2 レーザ 3 光軸合わせのためのガイドレール 4 検出部 5 フィルター 6 蛍光検出器 7 ハーフミラー DESCRIPTION OF SYMBOLS 1 Optical fiber 2 Laser 3 Guide rail for optical axis alignment 4 Detector 5 Filter 6 Fluorescence detector 7 Half mirror
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭57−45455(JP,A) 特開 平2−191674(JP,A) 特開 平5−107249(JP,A) 特開 平7−83925(JP,A) 特開 平6−222059(JP,A) 特開 平6−82449(JP,A) 特表 昭59−501873(JP,A) (58)調査した分野(Int.Cl.7,DB名) G01N 33/48 - 33/98 CA(STN)──────────────────────────────────────────────────続 き Continuation of the front page (56) References JP-A-57-45455 (JP, A) JP-A-2-191674 (JP, A) JP-A-5-107249 (JP, A) JP-A-7-54 83925 (JP, A) JP-A-6-222059 (JP, A) JP-A-6-82449 (JP, A) JP-T-59-501873 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) G01N 33/48-33/98 CA (STN)
Claims (3)
水溶性シアニン色素と、アミノ基を有する高分子化合物
とを結合させて蛍光標識試薬を製造する方法において、
N−アルコキシカルボニル−2−アルコキシ−1,2−
ジヒドロキノリンを作用させ、カルボキシル基とアミノ
基を選択的に結合させることを特徴とする蛍光標識試薬
の製造方法。1. A method for producing a fluorescent labeling reagent by combining a water-soluble cyanine dye having both a sulfone group and a carboxyl group with a polymer compound having an amino group,
N-alkoxycarbonyl-2-alkoxy-1,2-
A method for producing a fluorescent labeling reagent, comprising reacting dihydroquinoline to selectively bind a carboxyl group and an amino group.
水溶性シアニン色素が一般式(I)、(II)または(II
I)により表されるシアニン色素であることを特徴とする
請求項1記載の製造方法。 【化1】 (式中、RはH+ 、Na+ 、K+ 、Li+ 、N+ H(C
2 H5 )3 、NH4 + 、またはピリジニウムイオンを表
す。) 【化2】 (式中、RはH+ 、Na+ 、K+ 、Li+ 、N+ H(C
2 H5 )3 、NH4 + 、またはピリジニウムイオンを表
す。) 【化3】 (式中、RはH+ 、Na+ 、K+ 、Li+ 、N+ H(C
2 H5 )3 、NH4 + 、またはピリジニウムイオンを表
す。)2. The water-soluble cyanine dye having both a sulfone group and a carboxyl group is represented by the general formula (I), (II) or (II).
2. The production method according to claim 1, which is a cyanine dye represented by I). Embedded image (Wherein R is H + , Na + , K + , Li + , N + H (C
2 H 5 ) 3 , NH 4 + , or a pyridinium ion. ) (Wherein R is H + , Na + , K + , Li + , N + H (C
2 H 5 ) 3 , NH 4 + , or a pyridinium ion. ) (Wherein R is H + , Na + , K + , Li + , N + H (C
2 H 5 ) 3 , NH 4 + , or a pyridinium ion. )
ン、スルホン化キトサン、ポリガラクトサミン、ポリノ
イラミン酸、抗体、アビジン、およびプロテインAから
なる群より選ばれるものである請求項1または請求項2
記載の製造方法。3. The high molecular compound having an amino group is selected from the group consisting of chitosan, sulfonated chitosan, polygalactosamine, polyneuraminic acid, antibody, avidin, and protein A.
The manufacturing method as described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35085193A JP3294415B2 (en) | 1993-12-27 | 1993-12-27 | Method for producing fluorescent labeling reagent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35085193A JP3294415B2 (en) | 1993-12-27 | 1993-12-27 | Method for producing fluorescent labeling reagent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07191029A JPH07191029A (en) | 1995-07-28 |
JP3294415B2 true JP3294415B2 (en) | 2002-06-24 |
Family
ID=18413322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP35085193A Expired - Lifetime JP3294415B2 (en) | 1993-12-27 | 1993-12-27 | Method for producing fluorescent labeling reagent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3294415B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5388004B2 (en) * | 2008-03-07 | 2014-01-15 | 国立大学法人三重大学 | Near-infrared photoluminescent compounds and luminescent methods thereof |
EP2579027B1 (en) | 2010-05-31 | 2019-07-03 | Eisai R&D Management Co., Ltd. | Fluorescent probe for imaging lymph nodes |
-
1993
- 1993-12-27 JP JP35085193A patent/JP3294415B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH07191029A (en) | 1995-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2024548C (en) | Analyte specific chemical sensor | |
Blakeslee et al. | Immunofluorescence using dichlorotriazinylaminofluorescein (DTAF) I. Preparation and fractionation of labelled IgG | |
JP3327551B2 (en) | Reagents and methods for detecting and quantifying thyroxine in fluid samples | |
EP0134660B1 (en) | Polyether polyamines as linking agents for particle reagents useful in immunoassays | |
US7371745B2 (en) | Bis-transition-metal-chelate probes | |
JPS6116939B2 (en) | ||
JP2010210630A (en) | Method of labeling phosphorylated peptide | |
JP3294415B2 (en) | Method for producing fluorescent labeling reagent | |
WO1990013029A1 (en) | Reagent for assaying biologically active substance, method of production thereof, and method and apparatus for assaying | |
JP3130513B2 (en) | Bioactive substance measurement device | |
CA2586474A1 (en) | Lamotrigine analogs | |
JPS61130263A (en) | Bifunctional haptenes and manufacture | |
JP3354975B2 (en) | Fluorescent labeling reagent and fluorescent immunoassay | |
JPH0376422B2 (en) | ||
US6919333B2 (en) | Bis-transition-metal-chelate probes | |
JP3176163B2 (en) | Fluorescent labeling reagent and fluorescent immunoassay | |
JP3025078B2 (en) | Fluorescence analysis | |
CN116047052A (en) | Allophycocyanin fluorescent tandem dye, preparation method thereof and antibody coupling method | |
JPH0783925A (en) | Fluorescent labeled reagent and fluorescent immunity measurement method | |
JP3147992B2 (en) | Labeling reagent for immunoassay | |
US11186719B2 (en) | Hemicyanine dyes | |
JP2951398B2 (en) | Reagent for measuring bioactive substance, its production method and measurement method | |
JP3399598B2 (en) | Labeling reagent for immunoassay using N-partially substituted aminoglycan | |
WO2019213543A1 (en) | 2-[2-[4-[bis(2-sulfoethyl)amino]phenyl]ethenyl]-1-butyl-3,3-dimethyl-3h-indolium hemicyanine dyes for the detection of antibodies and other biomolecules | |
Pandurangi et al. | Chemistry of Bifunctional Photoprobes: 4. Synthesis of the Chromogenic, Cleavable, Water Soluble, and Heterobifunctional Sulfosuccinimidyl (N-methylamino Perfluoroaryl Azido Benzamido)-ethyl-1, 3′-Dithiopropionate: An Efficient Protein Cross-Linking Agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080405 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090405 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100405 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110405 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120405 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130405 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140405 Year of fee payment: 12 |
|
EXPY | Cancellation because of completion of term |